About: http://webisa.webdatacommons.org/76102515

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	GAITHERSBURG, Md. ?? An FDA panel Thursday said the risks of fetal exposure, increased heart rate, depression and other problems outweighed the benefits of weight loss for Vivus Inc.'s Qnexa (phentermine/topiramate). (BioWorld Today)
http://www.w3.org/ns/prov#wasQuotedFrom	bioworld.com